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EXECUTIVE SUMMARY 
 
The National Advisory Committee on Drugs (NACD) has, since its establishment four years ago, 
achieved significant progress in delivering against its mandate.  It has published a range of reports (25) 
on critical issues, particularly where existing research was inadequate or non-existent.  It has become 
the knowledge arm of the National Drugs Strategy providing advice to Government on a range of drug-
related issues and more recently participating in the National Drugs Strategy Review.  It has also begun 
a process for developing capacity for drug-related research in Ireland and demonstrated its ability to 
serve multiple audiences.   
Achievements against the Terms of Reference can be described as follows: 
• provided advice to Government 
• provided a focus for addressing knowledge deficits and research capacity 
• developed strong networks with relevant agencies to support research and distil evidence 
• met specific requests from Government 
• worked closely with the HRB, NDC established 
• have impacted on agencies through dissemination 
 
The NACD has a proven capacity to develop and manage research projects.  It has effective systems in 
place (for example contracts are sought by other agencies), it has an ability to demand and get best 
practice and it has established a public profile such that the NACD has become a highly credible 
organisation with an excellent reputation amongst stakeholders, including the media. 
 
This Business Plan sets out the NACD’s agenda for the next four years.  It is founded in the 
Committee’s commitment to supporting the National Drugs Strategy (NDS) and research gaps, while 
also taking account of the views of a wider group of stakeholders and of the recommendations of an 
independent review carried out earlier in 2004.  It embodies a set of goals and objectives centred on the 
management of a focused research programme and the provision of sound analysis, interpretation and 
advice.  The Operational Programme for 2005-2008 has four key elements.  These are: 
• Commissioned research 
• Grant-aided research 
• Internal research  
• Communications 
The commissioned research programme will focus on the completion of current research, involving 
some eleven different research projects, on undertaking a limited number of ‘follow through’ or repeat 
projects where this will yield substantial benefits, and on exploring areas of potential new study, 
particularly in rehabilitation and drugs and crime. Limited staff resources is an ongoing challenge for 
the NACD, particularly in the area of research/technical support.  The proposed Operational 
Programme will be enhanced by the engagement of a research assistant. 
In grant-aided research, the most significant element will be the anticipated continuation of the 
Community and Voluntary Sector Research Grant Scheme.  This has already delivered four 
community-based research projects.  The scheme will be evaluated in 2005.   
Internal research capacity has been developed to implement the Drug Trends Monitoring System, 
which is currently being piloted.  Focus will also be given to publication of ‘position papers’ that will 
provide timely insight for Government into current drug-related issues.   
A communications strategy will be put in place to optimise the impact of the various initiatives and 
outputs, in terms of provision of advice, dissemination of findings and promotion of the research 
agenda. 
The NACD has a funding allocation of approximately €1.3 million per annum and spending has, in the 
past, not necessarily reached that level.  This was largely because of the difficulties in initiating and 
completing the planned level of research activity within the limitations of existing research capacity 
and internal resources.   
The NACD will introduce a Balanced Scorecard, embodying a small number of key performance 
indicators, to monitor its progress against plan throughout the period 2005-2008. 
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BACKGROUND 
 
ORIGINS AND FUNCTIONS 
 
The NACD was established on a non-statutory basis, under the auspices of the Department of Tourism, 
Sport and Recreation, for an initial period of three years commencing in August 2000.  This period was 
subsequently extended to a fourth year ending in July 2004.  Since June 2002, the NACD has been 
under the auspices of the Department of Community, Rural and Gaeltacht Affairs. 
On its establishment, the functions of the NACD (the Committee) were set out as follows: 
• based on the Committee’s analysis and interpretation of research findings and information 
available to it, to advise the Cabinet Committee on Social Inclusion and, through it, the 
Government, in relation to the prevalence, prevention, treatment and consequences of problem 
drug use in Ireland; 
• to review current information sets and research capacity in relation to the prevalence, prevention, 
treatment and consequences of problem drug use in Ireland and to make recommendations, as 
appropriate, on how deficits should be addressed including how to maximise the use of 
information available from the community and voluntary sector; 
• to oversee the delivery of a three year prioritised programme of research and evaluation as 
recommended by the Interim Advisory Committee to meet the gaps and priority needs identified 
by: 
(a) using the capacity of relevant agencies engaged in information gathering and research, both 
statutory and non-statutory, to deliver on elements of the programme; 
(b) liaising with these agencies with a view to maximising the resources allocated to delivering 
the programme and avoiding duplication; 
(c) co-ordinating and advising on research projects in the light of the prioritised programme; 
(d) commissioning research projects which cannot be met through existing capacity; 
• to commission additional research at the request of the Government into drug issues of relevance 
to policy; 
• to work closely with the Health Research Board (HRB) on the establishment of a national 
information/research database (in relation to the prevalence, prevention, treatment and 
consequences of problem drug use) which is easily accessible; (The National Documentation 
Centre was officially opened in December 2002) 
• to advise relevant Agencies with a remit to promote greater public awareness of the issues 
arising in relation to problem drug use and to promote and encourage debate through the 
dissemination of its research findings. 
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ACHIEVEMENTS TO DATE 
 
 
Publications 
  
The main NACD publications are shown below by year of publication.  Publication represents the 
culmination of a research process; the actual research work will, in each case, have been undertaken 
over a (possibly extended) period and will have been subject to detailed review by the Committee prior 
to publication. 
 
2001 
1. Drug Use Prevention An Overview of Research  
 
2002 
2. Use of Buprenorphine as an Intervention in the Management of Opiate Dependence Syndrome  
3. Overview of drug prevalence information in Ireland – internal 
4. Consequences of drug use for communities - internal 
5. Research Ethics – Guidelines on Good Research Practice  
6. Overview of Research on Drug Misuse Among the Homeless in Ireland  
 
2003 
7. Approaches to Estimating Drug Use in Ireland 
8. Opiate Use in Ireland 2000 – 2001 key findings 
9. Opiate Use in Ireland 2000-2001 summary of methodology 
10. Report on Seminar on ‘Quality in Addiction Services’ 
11. Drug Use in Ireland & Northern Ireland First Results from the 2002/2003 Drug Prevalence 
Survey    Bulletin 1  
12. Drug Use in Ireland & Northern Ireland First Results from the 2002/2003 Drug Prevalence 
Survey Summary of Survey Methodology 
13. Use of Lofexidine in the Management of Opiate Dependence Syndrome 
14. Use of Naloxone in the Management of Opiate Dependence Syndrome 
15. An Overview of Cocaine Use in Ireland 
 
2004 
16. Progress Report July 2000 to July 2003 (Feb 2004) 
17. Opiate Use in Ireland 2000- 2001 Full Report (March 2004) 
18. Drug Use in Ireland & Northern Ireland 2002/2003 Drug Prevalence Survey: Health Board 
(Ireland) &  Health and Social Services Board (Northern Ireland) Results  Bulletin 2 (April 
2004) 
19. Harm Reduction Approaches in Ireland and Evidence from international literature (May 2004) 
20. An Overview of Scientific and other Information on Cannabis (Sept 2004) 
21. Ballymun Youth Action Project (BYAP) Benzodiazepines – whose  little helper? (Oct 2004) 
22. Kilbarrack Coast Community Programme (KCCP) A prevalence study of drug use by young 
people in a mixed surburban area (Oct 2004) 
23. Merchants Quay Ireland (MQI) Drug Use among new Communities in Ireland (Oct 2004) 
24. Tallaght Homeless Advice Unit (THAU) Heroin- the mental roof over your head (Oct 2004) 
25. The Management of Dual Diagnosis in Mental Health and Addiction Services in Ireland (Nov 
2004) 
26. The Role of Family Support Services in Drug Prevention (Nov 2004) 
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Advice to Government 
 
A key function of the Committee is, on the basis of analysis and interpretation of research findings and 
information available to it, to advise the Cabinet Committee on Social Inclusion and, through it, the 
Government, in relation to the prevalence, prevention, treatment and consequences of problem drug use 
in Ireland.  The following paragraphs outline some of the initiatives taken in response to specific 
Government requests and also some advice provided to Government to date. 
• The Minister of State with responsibility for the National Drugs Strategy requested the 
Committee to undertake research on the effectiveness of Buprenorphine in treating opiate 
dependence.  Based on the information gathered, the NACD provided advice to the Minister 
including the possibility of expanding its use in a pilot initiative amongst GPs. 
• At the request of the Minister of State and under Action 98 of the National Drugs Strategy, the 
NACD undertook research on vulnerable groups such as the Homeless and Travellers.  This 
research is nearing completion. 
• Under Action 99 the National Drugs Strategy the NACD commissioned a longitudinal study on 
drug treatment outcomes for opiate users, which is still underway. 
• Action 100 of the National Drugs Strategy required research to be carried out on Harm 
Reduction Approaches in Ireland and internationally.  Recommendations were made to 
Government. 
• Research on Cannabis was commissioned to provide an overview of the scientific and other 
information available.  Recommendations have been made to Government. 
• A report on Cocaine Use in Ireland was prepared for Government and recommendations were 
made. 
• At the request of Government, the NACD have established a Drug Trends Monitoring System, 
which will capture information from a wide range of sources and key informants on drug trends 
as part of the programme for Government.  It is currently in a pilot phase due to end in 
December 2004. 
• A briefing paper was prepared for Government on Heroin Trends outside of the Dublin Area and 
submitted in July 2004. 
Developing Research Capacity 
  
The NACD tendering process, structured on good practice public procurement guidelines and 
procedures, and targeted at a wide base of potential tenderers, has facilitated a widening interest in 
NACD research and has resulted in a growth in the number of tender applications over time.  The 
NACD has also worked very closely with commissioned researchers to develop clear parameters and 
quality standards for research and, through its intensive review process, has provided feedback to 
enable researchers deliver research of the requisite high standard. 
 
The NACD also established a Community and Voluntary Sector Research Grant Scheme, which also 
contributed to building research capacity in Ireland.  The first group of community research projects 
have been completed and it is hoped to continue this scheme in future years. 
 
THE NEXT FOUR YEARS 
 
An independent review of the work of the NACD was carried out in 2004 on behalf of the Department 
of Community, Rural and Gaeltacht Affairs.  The review concluded, in relation to the NACD, that “it 
meets a very real need and it provides the Government with excellent value for money”.  The key 
recommendation of the review was that “the NACD should be continued in its current role and its 
position in the Irish drug information and policy environment context should be maintained”. 
 
The mandate of the NACD to continue its work, in its present structure and with its current Terms of 
Reference, has now been extended for a further four years, to July 2008, to coincide with the life of the 
National Drugs strategy 2001-2008.  This Business Plan sets out a proposed framework for the 
NACD’s activities for that four-year period. 
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 STRATEGIC FRAMEWORK 
 
FOCUS AND PRIORITIES  
  
The strategic framework for the four-year Business Plan is based upon three key elements.  These are: 
1. The need to address ongoing research gaps 
2. Stakeholder views 
3. Recommendations from the independent review 
Remaining research gaps 
Having prepared the foundations for supporting a research and information era in Irish drug policy 
development, the NACD information and research base clearly points to continuing gaps in knowledge 
about drug-related issues in Ireland. 
In that context, the NACD has agreed that certain areas from the current work programme will need to 
be continued, for example: 
• in prevalence estimation (population survey, capture recapture estimate of heroin use, etc) 
• in the area of the consequences of drug misuse (further research with families); and 
• in treatment (monitoring effectiveness) 
• in prevention (models of good practice, delivery of prevention). 
 
In addition, a number of studies requested under the actions of the National Drugs Strategy will 
demand resourcing e.g. (vulnerable groups, further work on harm reduction), as will requests from 
Ministers, e.g. work on cocaine and psychostimulants and requirements under the Programme for 
Government dealing with Emerging Trends. 
Meeting these needs will form the core of the NACD’s strategy for the coming years and these 
priorities are reflected in the new work programme outlined later in this document.   
Stakeholder views 
Preparation of the Business Plan started in 2003 with the development of a consultation document 
widely circulated to over 200 key stakeholders, government partnership structures, interest groups, 
service providers and related agencies.  Feedback has been received from over 40 groups and their 
views have been carefully considered by the NACD in deciding on its priorities and formulating its 
plans.  The NACD, with the assistance of an external facilitator, participated in a one-day review 
meeting in December 2003 to tease out issues and lessons learned.  
Finally, the Committee has now agreed two new priority areas - namely - rehabilitation and drugs and 
crime. 
Review recommendations 
 
The independent review of the work of the NACD put forward a number of recommendations.  These 
are summarised in Appendix 5 to this document.  The NACD had already recognised and begun to take 
on board many of the recommendations dealing with internal organisation and procedures identified in 
the Review such as reducing the number of sub-committee meetings and boosting the use of ad hoc 
work or task groups.  In addition, the Review made the following recommendations for the NACD: 
• Build and sustain relationships with key stakeholders 
• Refine NACD structure and organisation of operations 
• Recruit additional research assistance internally 
• Reduce number of research projects 
• Develop measurable performance indicators. 
These recommendations have been carefully considered and, where appropriate, are reflected in the 
NACD’s planning for the future. 
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GOALS AND OBJECTIVES 
 
On the basis of the focus and priorities outlined above, the Committee has agreed the principal goals 
and objectives for NACD in the period 2005-2008.  The primary GOAL of the NACD remains 
unchanged and that is … 
To advise the Government, in relation to the prevalence, prevention, treatment 
and consequences of problem drug use in Ireland 
To achieve that goal, the NACD must have available to it the best information and research coupled 
with the knowledge and expertise of its Committee members to provide the necessary analysis and 
interpretation.  Two key factors – better research information and optimal use of members’ expertise in 
analysis, interpretation and advice – inform the underlying objectives for this Four-Year Business Plan.  
Thus the VISION is  …  
To provide a national focus for knowledge related efforts that inform Irish 
policy in relation to drug misuse. 
The specific objectives for NACD deriving from its goals and vision are summarised below. 
RESEARCH ANALYSIS, INTERPRETATION AND ADVICE 
Commissioned Research 
• Complete agreed commissioned research 
programme within the four-year period: 
o Completion of contracted research 
o Follow through / repeat existing work 
o New research 
Grant-assisted Research 
• Support further community/voluntary 
sector research grant scheme 
• Support RDTF/LDTF research projects 
where feasible 
Internal research 
• Implement pilot Drug Trends Monitoring 
System, review results and report on 
feasibility of full implementation 
• Prepare two briefing papers per annum on 
specific relevant topics 
Integration of information from all sectors 
• Develop and implement a 
communications strategy to include: 
o advocacy / promotion of the research 
agenda amongst key influencers, i.e. 
those who promote, undertake or 
fund drugs-related research 
o Promotion of debate through 
dissemination of research findings 
• Complete agreed publications programme 
within four year period 
• Establish a Memorandum of 
Understanding with the DMRD that 
includes the establishment of a data base 
of drugs-related research 
• Implement improved liaison with NDST 
 
Committees and members 
• Define optimum role for subcommittees 
• Develop appropriate Terms of Reference 
for standing sub-committees, RAGS and 
other project-limited subcommittees 
• Refine role of Management Committee 
• Minimise workload of members and 
focus members time and effort to best 
value 
• Improve process for submission and 
review of draft research reports 
• Develop process for identifying strategic 
developments in government requiring a 
submission from the NACD 
• Review process for preparation of 
submissions to Government. 
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OPERATIONAL PROGRAMME 
 
The Operational Programme for the period 2005-2008 is summarised in Appendix 3 to this document.  
The Programme shows the work planned, and the resources required to undertake the work, under the 
headings of: 
• Commissioned research 
• Grant-aided research 
• Internal research 
• Communications. 
It also reflects the time and resource requirements for necessary professional development work and 
for management and administration within the NACD. 
 
COMMISSIONED RESEARCH 
Research is one of the four pillars of the National Drugs Strategy 2001-2008, clearly reflecting the 
importance of having information and evidence to underpin policy-making in this diverse field.  
Commissioned research is one means of meeting requirements under this pillar, to fill gaps in 
knowledge and information regarding evidence based practice.   
The NACD has undertaken an extensive programme of research.  Given the limited staff resources of 
the NACD, the majority of the research must be commissioned externally and by public tendering 
procedures where possible.  This approach enables the NACD to undertake large and varied projects 
across a range of disciplines, agencies and institutions. The programme has already delivered across a 
range of topics and issues but it will be important, in order to realise full value from the research, to 
complete this programme.  This will be achieved over the next two years.  
Completion of current research 
Research Advisory Groups have provided support in both mentoring and monitoring the research 
projects.  We are particularly indebted to Dr Hamish Sinclair from the Drug Misuse Research Division 
of the Health Research Board and our colleagues in Northern Ireland in the Drug and Alcohol 
Information and Research Unit for their huge commitment since 2002 in overseeing the 
NACD/DAIRU Drug Prevalence Survey, a key epidemiological indicator.   
 
Completion of contracted research is made possible with the support of the many agencies external to 
the NACD who provide or gather data on our behalf such as local health authorities, the Drug 
Treatment Centre Board (Trinity Court), An Garda Síochána, hospitals and voluntary/community 
groups. 
 
There are a number of important research projects currently being carried out under contract to the 
NACD, to be completed and/or published in the coming period.  These are set out in the tables on the 
following pages 8, 9 and 10 below: 
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Project Title Contractor   Output   Completion 
Population 
study 
bulletins 
3,4,5… 
MORI MRC 
undertook the 
survey.  
DAIRU and the 
NACD are 
carrying out the 
analysis. 
 The First Drug Prevalence Survey in Ireland was 
commissioned in 2002 and undertaken by MORI 
MRC. It provides information on drug use 
amongst the general population, aged 15-64.  
This is one of the five key indicators of drug 
prevalence used by the EMCDDA. Bulletins 1 
and 2, already published, provided figures on 
drug prevalence in Ireland.  Bulletin 3 examines 
cannabis use and analyses a broader range of 
information, including age of first use, regular 
use, reasons for stopping, perceptions of risk and 
how cannabis was obtained.  This Bulletin will 
be published in early 2005.  It is envisaged that a 
fourth Bulletin will be prepared for mid 2005.  
The population survey will be repeated so that 
trend information can be provided to 
Government.   
 Bulletin 1 published 
October 2003,        
Bulletin 2 published 
April 2004,          
Bulletin 3 publish by 
May 2005            
Bulletin 4 publish by 
September 2005 
      
ROSIE NUI Maynooth 
- Dr Catherine 
Comiskey, Dr 
Gloria 
Crispino-
O'Connell and 
Dr Gemma 
Cox. 
 ROSIE is a national longitudinal study designed 
to evaluate the effectiveness of drug treatment 
and other intervention strategies used in Ireland 
for Opiate Dependence Syndrome with adults 18 
years and over.  The study will explore the pre-
treatment behaviours, problems and social 
circumstances of heroin users on arriving in drug 
treatment and then track their progress through 
treatment.  Over 400 heroin users have been 
recruited from 10 counties and over 50 locations.  
Interim reports are produced every six months to 
keep the NACD up to date and to monitor 
progress.  A baseline report is expected in early 
2005. 
 Results due in December 
2005.  Summary 
baseline data will be 
presented at the Harm 
Reduction Conference in 
Belfast in March 2005. 
      
Network 
Analysis 
NUI Maynooth 
- Dr Jamie 
Saris and Dr 
Catherine 
Comiskey. 
 A Network Analysis Study was commissioned to 
develop multipliers for use as another tool in 
estimating opiate prevalence in Ireland.  This 
study is being carried out by NUI Maynooth and 
is nearing completion.  It is anticipated that the 
research will inform discussions on the 
feasibility of establishing local drug prevalence.  
A final report is nearing completion and the 
NACD expect to report to Government by mid 
2005. 
 Completion 2005. 
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 Project Title Contractor   Output  Completion 
Community 
Study 
UCD - Dr 
Hilda Loughran 
and Dr Mary 
Ellen Mc Cann. 
 A two year study is being carried out by UCD 
into the community experiences of problem drug 
use and how or if this has changed since 1996.  
The study is exploring the experiences of three 
communities using local researchers and a 
combination of methods.  It is also expected to 
produce indicators of a community drug 
problem.  A first draft of the final report will be 
provided to the NACD in early 2005.    
 Completion September 
2005. 
      
Drug Use & 
Homelessness  
Merchants 
Quay Ireland 
Research Unit - 
Marie Lawless 
and Caroline 
Corr 
 Research was commissioned on drug use 
amongst the homeless which has been completed 
by Merchant’s Quay Ireland and due to be 
published in early 2005.  Findings will be 
considered by the NACD and recommendations 
made to Government.  As this was a 
collaborative process with the key agencies 
involved in working with homeless people, it is 
anticipated that a briefing seminar will be held to 
disseminate the findings to key stakeholders and 
interest groups.   
 Published in April 2005. 
      
Drug Use & 
Travellers 
Vision 21 - 
Simon Danzuk 
and Jonathan 
Breeze in 
collaboration 
with the Centre 
for Ethnicity 
and Health 
University of 
Lancashire 
 This was the second research project 
commissioned in the area of vulnerable groups 
and is being carried out by Vision 21.  The 
research is in its final stages and a completed 
draft report was received in autumn 2004.  It is 
not anticipated that the report will be published 
as of yet but used as an internal document to 
support Government policy development in 
addressing health and social needs of Travellers.   
The collaboration with the Centre for Ethnicity 
and Health, Traveller service organisations and 
interest groups will be continued in finalising the 
report and disseminating findings to key players 
in service delivery to Travellers. 
 Completion 2005. 
___________________________________________________________________________________________________________ - 9 -
  
  
 Project Title Contractor   Output   Completion 
Capture 
Recapture 
Method 
(CRM) 2-
Source 
Small Area 
Research Unit, 
Trinity College 
- Dr Alan 
Kelly, Conor 
Teljeur. 
 The Small Area Research Unit of Trinity College 
are developing prevalence estimates using the 
Capture Recapture method and two data sources 
(CTL  and Garda Study).  The objective is to test 
the application of the method to local area 
statistics in order to develop local prevalence 
estimates.  Work is ongoing and the study should 
be completed by early 2005.  A draft report is 
expected in February 2005.   
 Completion mid 2005 
      
Evaluation of 
the National 
Drug 
Awareness 
Campaign 
NUI Galway - 
Dr Saoirse Ni 
Gabhainn and 
Dr Jane 
Sixsmith. 
 The NACD commissioned a research project to 
track the effectiveness of the National Drug 
Awareness Campaign over its 3-year life cycle.  
NUI Galway is carrying out the research, which 
will examine the various tools and approaches 
used in developing and implementing the 
campaign.  There are three phases to the 
research: phase one examined the developmental 
aspects of the campaign including the first wave 
of advertising, phase two is examining 
implementation of the first and second wave of 
advertising and phase three is examining the 
third and final wave of advertising, providing for 
triangulation of data and analysis culminating in 
one final report.   The research is due to be 
completed by December 2005.  Findings will be 
used to enhance the approach to and 
development of Drug Awareness Campaigns, 
identifying key lessons learned for the future. 
 Due to finish end of 
2005, final report due 
early 2006.  
      
Family Study Contract  
awarded to Dr 
Carmel Duggan 
of WRC Social 
and Economic 
Consultants 
 Developmental work has taken place on a 
research project that will investigate how 
families cope with drug problems, where they 
seek support and what their experience of 
services are in general.  The tender was 
advertised in October 2004, the contract awarded 
in March 2005.  The project will start in May 
2005. 
 Draft final report 
expected in December 
2005 completion of 
project expected by end 
March 2006 
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Follow through / repeat existing work 
 
In certain areas of research, the greatest value is derived from repeating or extending specific pieces of work in 
order to identify key trends or behaviours over time.  The NACD plans to undertake a small number of such 
studies in the coming four-year period. 
 
Population Drug Prevalence Survey 2005-2006 
In order to establish population drug prevalence trends it is essential to repeat the population survey.    This will 
be commissioned through external contract work via public tendering procedures.  Due to the value of the 
contract it will be advertised in the EU Journal (OJEC).  Advertisement will take place in either Autumn 2005 or 
Spring 2006, the contract will be awarded mid summer, the fieldwork will commence in October 2006 and be 
completed by May 2007.  The new drug prevalence figures and trends will be available by late autumn 2007.  It 
will be important to factor in the cost of delivering this without the collaboration of our Northern colleagues 
should their priorities change.  As the CAPI (Computer Assisted Interviewing) method will be required for face-
to-face interviews, costs are likely to be substantially greater in the commissioning of this study. 
 
3-Source Capture Recapture Method 
The Capture Recapture Methodology (CRM) is used to determine an estimate of problem opiate use by 
combining 3 data sources (Garda data, HIPE1 data, and CTL2 data).   Repeating this study would give NACD 
valuable trend information relating to heroin use.  This study will need to be repeated again in 2007.  However, 
much of the preparation for implementing this project is needed in 2005/2006, such as obtaining ethical 
approval, clearance from the Data Protection Commissioner, advertising the tender and awarding the contract.   
Data will be collected and analysed for the period 2005.  A report is expected for late 2007. 
 
Research on Drug Use amongst Vulnerable Groups 
Further to the Ministerial request to carry out research amongst vulnerable groups, the NACD intends to 
investigate what information gaps exist relating to drug use among early school leavers and prostitutes.  
Background work will be carried out internally in 2005 (workload permitting) and research may be 
commissioned in late 2005, early 2006 if necessary.  This area of work will not be prioritised for 2005.   
 
Harm Reduction, Suicide, Overdose 
As a follow up to the recently published report, the NACD would like to identify information needs relating to 
drug use and suicide and drug use and overdose.  These are areas where interventions can be put in place to 
reduce risk of harm based on the analysis of information gathered. 
New research 
 
On its establishment in 2000, the NACD adopted a programme of work that focused on the main areas of need 
in relation to drugs-related research, primarily upon the key questions of prevalence and treatment.  Much 
progress has since been made in these areas (See Appendix 9)  and the Committee is now evaluating new 
priority areas.  Two key areas have been identified to date – rehabilitation and drugs and crime. 
 
Rehabilitation 
In progressing research in this area, the NACD intends to first convene a stakeholder consultative group.  The 
objective of this group will be to consider information currently available in Ireland relating to the experience of 
drug rehabilitation and social reintegration, to identify gaps and develop a key research project if necessary.  It 
is expected that the ROSIE study will provide some information relating to rehabilitation depending on the 
follow up rate.  It may be possible, to extend follow up for a further two years to enhance the rehabilitation 
information, however, this would need the commitment of substantial funds.  Commissioning of preliminary 
research will take place in 2005 such as mapping services, identifying models and reviewing the international 
and national literature.  A larger study, if necessary, is unlikely before 2006.   
                                                 
1 HIPE Hospital In-Patient Enquiry – Records of admissions and discharges to Irish hospitals 
2 CTL Central drug Treatment List 
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Drugs and Crime 
There is a need to understand Irish drug markets and to determine the nature of the relationship between drug 
use and crime.  A consultative group of key stakeholders was convened in 2003 to identify research gaps and it 
is intended to reconvene this group to support the development of a relevant research project or projects.  A 
collaborative process is envisaged in the commissioning, implementation and report preparation stages.  
Commissioning of the research is unlikely before 2006. 
 
GRANT-AIDED RESEARCH 
 
NACD’s experience to date has highlighted the need for development of research capacity in Ireland.  
Commissioned research has a role in this area, particularly through the mentoring role of research advisory 
groups. Grant-aided research is also a potential means of developing the knowledge and skills required both to 
undertake and manage research initiatives.  NACD will seek to develop this aspect through the implementation 
of a focused programme of research supports, to include:   
• Continuation of its existing Community and Voluntary Sector Research Grant Scheme 
• Support to Regional and Local Drug Task Force research initiatives. 
 
Community and Voluntary Sector Research Grant Scheme 
The grant scheme was launched in 2001 with the aim of generating community-based drugs research.  Contact 
was made with several agencies to gain insight into their approach to implementing and managing research 
grant schemes.  Four organisations have successfully completed research projects and produced individual 
reports for the NACD.  All of the reports were published in October 2004 and are available in print and from the 
NACD website. 
 
Evaluation of the Scheme outputs has been commissioned and will be completed by mid-2005.  Subject to a 
positive evaluation, it is anticipated that, this grant scheme will be operated again.  A high level of technical 
support was required by all the projects involved in the scheme.  Throughout the two years of the grant scheme 
the Research Officer attended over 50 meetings and gave over 70 days per year to the running of the scheme. 
Given the limited resources available to the NACD, should the scheme be implemented in the new work 
programme, it will require substantial resources to operate from both an administrative and technical perspective 
and thus may need to operate differently.   
 
Regional and Local Drug Task Forces 
NACD support will be made available on an annual basis to support the needs and capacity of the drug task 
forces to carry out locally based research that would fill gaps in our knowledge and contribute to building 
capacity.  Moreover this approach would also encourage greater understanding of the value of information, the 
ethical issues involved in managing access to that information and importance of routine data collection for 
administrative and research purposes.  There is limited time available in 2005 for this; therefore, the best use of 
resources would be to facilitate a research workshop or seminar.  Greater levels of support could be provided 
from 2006 onwards. 
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INTERNAL RESEARCH 
Drug Trends Monitoring System 
 
The NACD has established a Drug Trends Monitoring System (DTMS) to meet the objectives set out under the 
Programme for Government and the National Drugs Strategy for the identification of new or emerging drug 
trends.  The aim of the system is to identify trends such as the spread of heroin into new areas, the availability of 
new drugs, new patterns of drug use and new drug users groups. This is consistent with our Terms of Reference 
in the February 2000 Report from the Interim Advisory Committee: “a person should be designated at local 
level to report on more general information coming to hand, such as for example, emerging patterns in problem 
drug use.” A pilot model for the DTMS has been developed which is in the process of being tested and 
established. In this system, the emphasis is on tapping into drug trends at the early stage of their lifecycle. This 
will be achieved through the establishment of: 
  
i) A network of trend monitors of frontline workers throughout the country who would complete a short 
trend questionnaire on the drug situation in there areas. Monitors would also alert the NACD when a new 
trend develops. 
ii) A media monitoring system which will allow the monitoring of drug seizures, drug related court cases, 
and local drug issues around the country. 
iii) A series of Focus Groups with drug user groups to assess latest drug trends. 
 
Data from all sources will be collated and trends assessed, validated and fed through to the Early Warning and 
Emerging Trends sub-committee of the NACD.  Reports on the findings of the Monitoring System (if 
implemented) will be presented on an annual basis and Alert Notifications will be issued as required. 
 
Evaluation process and decision timelines 
Data collection was initiated in October 2004.  The data was analysed in a preliminary report prepared for the 
NACD Early Warning Emerging Trends Sub-committee in December 2004.  A full review of the 
implementation will be prepared for February 2005.  Once the final report has been prepared the sub committee 
will consider the merits and cost/benefit of a full implementation of the monitoring system and who might be 
best placed to implement it.  The project is not considered in our resource planning beyond this pilot stage. 
 
Public Health Issues 
Exploratory research has been carried out on the issue of HIV in communities.  The objective was to gain a 
social and historical background to the prevalence figures for HIV in communities where significant differences 
in similar populations have been identified.  It is anticipated that a more detailed study relating to the harm 
reduction may emerge.  Issues concerning Hepatitis C are emerging as part of this exploratory study which will 
need further investigation. 
Position papers 
The key role of position papers is to provide timely insight into emerging or developing drug-related issues. It is 
anticipated that it may be possible to produce at least one position paper per year and produce four by 2008 for 
Government.  In 2005, one paper will relate to the DTMS and baseline information on trends or patterns of drug 
use.  Further position papers over the coming years could relate to any one of the following examples: 
• Poly drug use 
• Cocaine use in Ireland 
• Issues relating to prescribed drug use from the population survey 
• Children and Young people, drug use by those aged 15-24 
• Children aged 10-15 and their drug use. 
The NACD will, in the context of emerging priorities and anticipated Government requirements, seek to identify 
the specific area to feature in a position paper to Government at the beginning of each year and will determine 
the approach and resources required to produce it. 
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COMMUNICATIONS STRATEGY 
 
The functions of the NACD necessitate communication for many different reasons and at different levels.  It 
must first of all interpret its research findings and “advise … Government in relation to the prevalence, 
prevention, treatment and consequences of problem drug use in Ireland”.  It must be able to propose “how to 
maximise the use of information available from the community and voluntary sector” and to promote this 
objective in those sectors.  It must also be able “to advise relevant Agencies” and “to promote and encourage 
debate through the dissemination of its research findings”. 
 
All of these, and indeed other, elements are required and can best be coordinated through an integrated 
communications strategy which the NACD will develop for the four-year period now beginning.  The 
Communications Continuum below provides a synopsis of the target audience and communications medium 
opportunities for the NACD. 
 
The objectives of the communications strategy will be: 
• To provide timely advice and briefings to the Minister on key issues and emerging trends 
• To advise service providers and practitioners across sectors of relevant research findings that may inform 
current thinking and practice 
• To promote the research agenda amongst key influencers in those Agencies and bodies that promote, 
commission, fund or undertake drug-related research and/or have access to relevant data in this field 
• To represent the NACD and Ireland at international fora. 
Communications continuum 
 
 
Communications Continuum
PolicyAdviceAdvocacy KnowledgeAwareness
 DCR&GA / Drugs Strategy Unit
 Inter-Departmental Group
 National Drugs Strategy Team
 Cabinet Committee on Social 
Inclusion
 RDTFs
 LDTFs
 Health Services Executive
 Prisons
 Citywide
TA
R
G
ET
 A
U
D
IE
N
C
E
C
O
M
M
U
N
IC
A
TI
O
N
 M
E
D
IU
M
 Annual Report
 Presentations to key audiences
Press Briefings  Information Dissemination 
Seminars
 Potential Publications:
 Population Survey
 ROSIE
 Homeless
 Travellers
 DTMS
 Community Study
 Government 
Briefing Papers
 Reviews:
 Drugs and Crime
 Rehabilitation
Launch Events
 Contact programme 
with key influencers
 Through the diverse 
audiences
 Media events and 
opportunities
 Guest attendee at 
conferences & seminars
 Dept. Health & Children
 Dept. Education & Science
 Dept. Social & Family Affairs
 Dept. Justice, Equality & Law 
Reform
 Dept. Community Rural & 
Gaeltacht Affairs
 RDTFs
 LDTFs
 Community /Voluntary Sectors
 Professional bodies
 Statutory bodies
 Other government departments
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The main components of the communications strategy will be: 
• A communications plan that will link together all of the main features and outputs of the NACD’s 
Operational Plan and research programme  
• Build and sustain relationships with key stakeholders 
• A structured set of outputs that will include, inter alia: 
o Progress reports to Government and other stakeholders, promote value of research 
o Government briefing papers 
o Press briefings on publications 
o Presentations to key audiences such as IDG, NDST, Senior Officials, Health Services Executive 
o Disseminate published reports. 
Output goals: 
Note: not all output items stated are intended as publications  
 
Communications continuum 2005 2006 2007 2008
Population Survey B=Bulletins B1, B2(revisions) B3 & B4 B5, B6, B7 B8, B9, (New Survey Results) B10, B11, B12
ROSIE Baseline Results Final Results Rehab paper
Conference paper Conference paper(s) Polydrug use
Network Analysis Final Report
Community Study Final report. Pub summary Final Report publication Insights papers x 2
Drug use & Homelessness Report publication Focus group update paper
Drug Use & Travellers Final report Focus group update paper
CRM 2 Source Final report 3 source report 3 source regions
National Drug Awareness Campaign phase 2 report Final report
Interagency working Briefing paper update paper
Drugs and Crime Preliminary briefing Research Research Research report 1
Rehabilitation Preliminary briefing Research Research Research report 1
DTMS Report on Pilot
Family Study Final report
HIV Study Summary paper issues
Postion papers DTMS Briefing for Gov Position paper (s) Position paper (s) Position paper (s)
LDTF /RDTF support Workshops Workshops Preparing research reports support publications
Report writing Guidelines 
Community Grant Scheme Evaluation Advertise new scheme Reports Reports
Other Risk Groups Background work Briefing paper Briefing paper 
Annual Report Annual report 2004 Annual report 2005 Annual report 2006 Annual report 2007
Maximum number of publications 6 6 6 6
Minimum  no. of publications 3 3 3 3
Standard set in NACD  Review 1 report per 1.4 employees in NACD, per year  
 
 
Media coverage for the NACD has been extensive for most publications.  Invariably, it has included all major 
national papers (Irish Times, Irish Independent, Irish Examiner), national and local Radio news programmes and 
some current affairs features and TV coverage as news item was achieved 2-3 times in the year.  We expect this 
level of media interest to continue and we will endeavour to maintain good relationships with the media. A 
company will be engaged to assist in this area.  
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ORGANISATION 
 
COMMITTEES 
Committee membership 
The maintenance of a broad-based committee system is critical to the success of the NACD.  From its initial 
inception there was a strong view that the Committee itself should include representatives from the voluntary 
and community sector, Government Departments and State agencies, and academic and research interests.  The 
2004 review of the work of the NACD also found that the various sub-committees had been central to the very 
significant progress made by the NACD in its first four years of operation.  It is therefore a key objective for the 
NACD to ensure that it continues to have available to it the range of expertise and experience necessary to fulfil 
its mandate and to be able to offer comprehensive and balanced advice on the full range of drug-related issues. 
The demands of committee and sub-committee participation are considerable.  Apart from actual attendance at 
meetings, there is a heavy commitment required in reading and reviewing significant volumes of documentation 
and in other committee-related activities. The 2004 review also found that there was potential for overlap 
between the different sub-committees, possibly leading to duplication of effort and procedures. A further 
objective, therefore, is to ensure that the Committee and sub-committees operate in a manner that will make 
most effective use of the members’ time and expertise.  
 
Draft terms of reference will be developed for each type of sub-committee and the key points for each are 
summarised below. 
 
Sub-committees  
The NACD utilises a structure of five sub-committees (see Appendix 7) to examine relevant issues in the areas 
of prevalence, prevention, treatment, consequences and early warning / emerging trends.  The sub-committees 
have been important in enabling the NACD to address an extensive research programme. They have undertaken 
much of the detailed work involved in framing appropriate research questions, in commissioning the research 
and in reviewing and shaping the outcomes of the research in terms of draft reports submitted to the Committee 
for consideration.  More recent use of Research Advisory Groups (RAGs) to oversee individual projects has, 
however, led to some perceived overlap of functions and duplication of review.  
 
However, the sub-committee structure is an effective way for the NACD to monitor progress and conduct 
strategic thinking on issues that may require further investigation as part of the work programme.  There may be 
questions and issues, e.g. drug-related issues across particular groups, which require a more integrated approach 
than the sectoral focus of the current sub-committees, i.e. prevalence, prevention, treatment, consequences and 
emerging trends.   
  
With those issues in mind, it may be appropriate for the NACD to adopt a more flexible approach to the role and 
membership of the sub-committees.  The sub-committee should, as heretofore, undertake the role of identifying 
the needs, formulating the key research questions and guiding the research programme in its area of 
responsibility.  It should, however, provide direction at a high level, with the Research Advisory Groups taking 
responsibility for the direct management and delivery of research projects.  It should meet at, say, quarterly 
intervals and should also be time-limited to the duration of its agreed programme.  Membership would therefore 
vary from time to time, depending on its particular focus at that time. 
  
Terms of reference for each sub-committee may include the following key responsibilities: 
1. Evaluate and determine the research needs for a specific sector or area of focus 
2. Agree the research approach and agenda 
3. Formulate the key research questions  
4. Review and, if appropriate, approve research proposals 
5. Monitor progress on research projects. 
6. Support the development of position papers to the NACD. 
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Research Advisory Groups 
  
The primary role of the Research Advisory Group is to guide and manage research projects from inception to 
completion.  Terms of reference will therefore include the following: 
1. Monitor and support the research through each stage of development 
2. Agree the project objectives document. 
3. Inform the research process and agree the development or enhancement/changes to the design 
4. Provide practical advice where difficulties emerge during the various stages of research 
5. Ensure ethical approval is obtained where necessary from the relevant research ethics committee. 
6. Observe the publication and copyright policy of the NACD as stated in the NACD contracts 
7. Oversee the project management of the research tracking milestones and progress 
8. Review drafts of progress and final reports providing feedback where appropriate re the needs of the 
NACD in terms of content for consideration and publication 
9. Report to the NACD and the appropriate sub-committee on progress of research projects 
10. Sign off on the final draft of the report to be submitted to the NACD for approval and agreement on 
recommendations to be made to Government. 
 
Management Committee 
The Management Sub-committee has been an important element in NACD achieving its objectives to date and 
the independent review recommended a continuing and enhanced role for the sub-committee.  
 
Its terms of reference will include the following: 
1. Provide support to the Executive to carry out the objectives of the work programme 
2. Assist in managing resource issues work distribution, performance etc 
3. Assist in resolving administrative issues in areas such as recruitment, holiday/sick leave relief, etc 
4. Review and approve contracts to be awarded to contractors, amendments to contracts and financial issues 
5. Assist in the resolution of issues or disputes in relation to research contracts or other NACD matters 
6. Review and support the NACD’s communications strategy. 
 
 
NACD STAFFING 
Organisation 
 
There are four core staff employed to work for the NACD – a director, research officer, administrator, and 
clerical support.  The latter two positions are placements from the Department of Community, Rural and 
Gaeltacht Affairs to the NACD and they remain part of the department’s core staff complement.  The director 
and research officer are on fixed term contracts with the Department of Community, Rural and Gaeltacht Affairs 
to work with the NACD.  It is possible for the NACD to employ temporary staff from time to time to assist with 
the demands of a heavy workload although this has been predominantly administrative.  One temporary research 
assistant is employed until March 2005 to work with the research officer in implementing the Drug Trends 
Monitoring System.   NACD staffing is currently organised as follows: 
DIRECTOR 
 
 RESEARCH OFFICER ADMINISTRATOR CLERICAL OFFICER 
General research assistant (temp) 2005-2008
Research assistant DTMS 2004-2005
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Roles and responsibilities   (see Appendix 2 for summary job descriptions) 
 
Director 
The core function of the Director is to develop and implement the work programme and agree priorities with the 
NACD.  In addition, the Director must provide the administrative backup to the Committee and sub-committees 
and organise their ongoing research programme. There is additional responsibility to develop links, and interact, 
with other bodies relevant to the Committee’s work programme, both in Ireland and abroad.  The post also 
involves presenting information on the work and output of the Committee and raising public awareness of its 
role.  
 
Research Officer 
The core responsibilities of the research officer are to monitor and mentor research projects.  The Research 
Officer is required to work with consultants, researchers, and research organisations to ensure efficient and 
speedy implementation of the Committee’s prioritised work programme.  The Research Officer is required to 
liaise with the DMRD and other key players in the area of research and information in relation to drugs.   The 
Research Officer reports to the Director in relation to the Committee’s ongoing workload.   
 
Administrator 
The primary role of the Administrator is to prepare annual budgets, monitor expenditure and organise the 
meetings of the NACD and its sub-committees, ensuring timely circulation of papers.  In addition, the 
administrator will liaise with the Research Officer in monitoring ongoing research projects.  The Administrator 
will also carry out duties assigned by the Director, particularly in relation to the requirements set out in the 
Committee’s Rules of Procedure and Terms of Reference.   
 
Clerical Officer 
The role of the Clerical Officer is to provide support to the Director, Research Officer and Administrator so as 
to ensure the smooth running of the office on a day-to-day basis.  It also involves maintaining up-to-date files, 
both electronically and in paper-based systems, and recording all information necessary to the running of the 
office.   The Clerical Officer is also required to undertake reception and telephone duties, IT support and to 
provide an efficient response in dealing with queries in accordance with NACD’s Customer Service Charter. 
Workload and resources 
The estimated workload and resource requirements of the Operational Programme are summarised in Appendix 
3.   This shows, for each area of work, the major projects and activities to be undertaken, their expected duration 
and the work inputs required for their completion.  The inputs, expressed in days, are shown separately for the 
Director, the Research Officer, NACD administration and sample of days required for external or contracted 
support.  The specified days are those estimated to be required to complete the research projects through to 
publications and events, and are based on NACD’s experience thus far. 
  
New staff 
At the time of writing, the staff at NACD is working to excess capacity on a daily basis. The NACD recognises 
this is not acceptable on an ongoing basis and the Department has responsibilities under the Health, Safety and 
Welfare at Work Act. It is critical for the successful implementation of this business plan that the NACD 
increase the staffing capacity immediately. The NACD will engage an employment agency to provide a research 
assistant (see Appendix 3, Job Description,) over the coming years and temporary administrative relief when 
required.  
The options for managing this lack of capacity are clear.  Ideally, recruitment of additional staff would fulfil our 
needs as set out in the Talbot Review of NACD, however, public sector ceiling on staffing prevent this.  
Therefore as an alternative approach, the necessary resources can be contracted externally on a temporary short-
term project specific contract, in the areas where external support is required, including: 
• Technical expertise for population survey work 
• Technical expertise for community/voluntary sector 
research grant scheme 
• Research assistance with DTMS 
• Policy briefing papers 
• Proof reading 
• Database management 
• PR and event management 
• Administration  
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FINANCE 
 
CASH FORECASTS     
 
The NACD has a funding allocation of approximately €1.3 million per annum.  This is a substantial level of 
funding and spending has, in the past, not necessarily reached that level.  This was largely because of the 
difficulties in initiating and completing the planned level of research activity within the limitations of existing 
research capacity and internal resources.  The pattern, however, is likely to change.  A continuing research 
programme combined with a greater use of external resources and funding of grant-aided research, will call for 
higher levels of expenditure.  This is reflected in the forecast figures. 
 
Expenditure components 
 
The main expenditure components are as follows: 
 
Annual costs: 
Salaries 
Non pay admin 
Web management 
Legal 
PR 
Event management 
Advertising 
Publications 
Travel 
Consultancy short term/small projects 
 
Research Programme: 
Complete ongoing research commitments (ROSIE, CRM 2-source, Community Study, Risk Groups etc.) 
Family Study   
Capture Recapture Method Repeat 3-source 
Population survey repeat 
Vulnerable groups  
Drugs and crime  
Rehabilitation  
 
Grant-aided research: 
Community / Voluntary Sector Research Grant Scheme  
LDTF and RDTF support 
 
Internal research: 
Drug Trend Monitoring System full completion of pilot 
Policy position papers  
HIV Study 
 
BUDGET MANAGEMENT 
The budget will be managed on a monthly basis with reports provided on a quarterly basis to the NACD.  The 
reports will outline the funding committed for research or other projects and the amount of funding expended to 
date.  Our own records will reflect expenditure according to contracts, plans and any over or under spend will be 
alerted to the NACD. 
_________________________________________________________________________________________________________ 
    - 19 -
    
PERFORMANCE MEASUREMENT 
 
The Committee has, in its previous business plan, identified the need to introduce an improved basis for 
monitoring its activities and performance.  This was supported by one of the recommendations of the 
independent review, which suggested that the NACD should develop a small set of Key Performance Indicators, 
utilising a Balanced Scorecard approach. 
The NACD should start the measurement process with a limited number of measures, focusing on those that are 
most relevant to the strategic management of its activities.  It is therefore proposed that the NACD should 
develop its reporting using the type of measures outlined below and in Appendix 6 to this document.  These 
measures are linked to the goals and objectives set out in this Business Plan. 
Overall performance should reflect a balanced view of the NACD’s progress across all of its key functions.  
This will include: 
 Client service 
 Internal efficiency 
 Financial management, and 
 Integration. 
 
CLIENT SERVICE 
The Government, through the Cabinet Sub-Committee, Minister of State and the responsible Department 
(Community, Rural & Gaeltacht Affairs), is the NACD’s primary client.  Client service measures should be 
focused on the NACD’s ability to respond to Government requirements, as expressed in specific questions or 
requests, and in the specific actions required of the NACD under the National Drugs Strategy.  Proposed initial 
measurements will relate to: 
 Responses to Government Questions (status and timing against plan) 
 Actions required by Drug Strategy (status and timing against plan) 
 
INTERNAL EFFICIENCY 
The focus of internal activities, and measures, will be the delivery of agreed programmes of research and 
effective management of the projects involved.  Proposed initial measures will relate to: 
 Commissioned Research (project status against plan) 
 Grant-assisted Research: 
o Community research programme against plan 
o Support to LDTFs and RDTFs 
 Internal Research (Internal research projects against plan, project status against plan) 
 Project management (project delivery against plan; issue management against plan) 
 
FINANCIAL MANAGEMENT 
There are specific characteristics of research-based expenditure that require careful monitoring.  Expenditure is 
often committed considerably in advance of actual spend and may run over a number of financial years. In 
addition, actual disbursement is tied to the delivery of research and the timing will be affected by the extent to 
which projects are delivered on time.  It is necessary, therefore, to monitor both commitment of funds and actual 
spend.  Proposed initial measures will relate to: 
 Funds committed against plan (to date and projected) 
 Actual spend against budget (to date and projected) 
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INTEGRATION 
Key functions of the NACD are to maximise the use of the information available from the community and 
voluntary sector, to use the capacity of relevant agencies to deliver on elements of the research programme and 
to promote and encourage debate through dissemination of its research findings.  This role requires co-
ordination and co-operation (integration) with other agencies and organisations. Proposed initial measures for 
integration are: 
 Number of projects submitted to NACD for comment/input 
 Number of occasions NACD material used by other organisations3. 
 
 
                                                 
3 Periodic client survey required and key stakeholders to ascertain assimilation of our work into their planning and practice. 
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APPENDICES     
APPENDIX 1: MEMBERSHIP NACD 2005 
Dr Barry, Joe - Specialist in Public Health Medicine, Dept of Community Health and General Practice, Trinity College (Academic) 
Ms Byrne, Catherine - Dept. of Justice Equality & Law Reform, (Government) 
Mr Collins, Willie - Regional Health Board Representative, Health Services Executive (Statutory Agency) 
Dr Corrigan, Des - Chairperson, School of Pharmacy, Trinity College (Academic), Chair also Prevalence sub committee 
Ms Corrigan, Maria - Principal Psychologist, St John of Gods, (Ministerial Appointment) 
Mr Geoghegan, Tony - Merchants Quay Ireland, Irish Association of Alcohol and Addiction Counselling, (Specialist) 
Mr Morgan, Cathal, Health Service Executive Representative, Northern Area, (Statutory Agency)  
Ms Kavanagh, Mairéad -Ballymun Youth Action Project, Voluntary Drug Treatment Network, (Voluntary Sector) 
Dr Keenan, Eamon -Consultant Psychiatrist in Substance Abuse, Health Services Executive (HSE) (Statutory Agency) and Chair Treatment/Rehab sub 
committee 
Dr Mc Cann, Mary Ellen - Vice Chairperson, Dept of Social Policy and Social Work, UCD (Academic) and Chair Prevention sub committee 
Mr Melaugh, Brian - Ana Liffey Drug Project, Voluntary Drug Treatment Network, (Voluntary Sector) 
Mr Moloney, David - Dept. of Health & Children, (Government) and Chair Early Warning Emerging Trends sub committee 
Supt O’Brien, Finbarr - Garda National Drug Unit (Statutory Agency) 
Mr O’Brien, Liam - Community Addiction Response Programme Killinarden, (Community Sector) 
Ms O’Connor, Patricia - National Drugs Strategy Team (Government) 
Dr O’Sullivan, Maírín - Dept. of Education & Science, (Government) 
Ms Quigley, Anna - Citywide Drugs Crisis Campaign, (Community Sector) and Chair Consequences sub committee 
Dr Sinclair, Hamish - Drug Misuse Research Division, Health Research Board (Statutory agency) 
Ms Stack, Kathleen - Dept. of Community, Rural & Gaeltacht Affairs (Government)
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 APPENDIX 2:  SUMMARY OF JOB DESCRIPTIONS FOR FIVE STAFF  
Director Research Officer Assistant to Research Officer Office Manager Clerical Officer
Develop Strategic Direction with NACD Support development & implementation Support ongoing work of NACD Assist with budgeting Provide secretariat support to office
Ensure efficient discharge of business of NACD  of NACD work programme Prepare background info for Monitor and report on finances Purchase office supplies
Promote work of NACD, represent NACD Provide research technical support  briefing papers Recruit support staff Process invoices
Arrange distribution of NACD  to NACD, Director, SC & RAG structures Support work of RAGs and SCs Negotiate and manage contracts Support customer service
 business among its staff Oversee research projects Conduct desk research Monitor provision of progress reports Maintenance of office equipment
Develop core functions such as: Prepare position papers Initate and manage research projects Manage procurement process IT management
 HR, IT, finance, research mgmt Prepare research tenders Carry out literature reviews Assist with publications process Secretarial support to NACD structures
Develop internal/external communications Provide ongoing monitoring of Support development of Provide secretariat function to NACD Deal with public enquiries
Oversee operational effectiveness  research quality  position papers Support implementation of work programme Support the media monitoring of DTMS
 (organisational development) Support publications process Assist with running focus groups Manage office administration + admin staff Organise dissemination of reports
Prepare detailed work programme Establish new research projects Analyse data held in SPSS Ensure translation of docs where required Update website
Prepare detailed budgets Develop and expand DTMS, provide Support publications process Assist with annual report Organise launches and other events
Oversee implementation of work prog   analysis and write reports on DTMS Review draft reports and comment Prepare Ministerial briefings Develop contacts database
Provide Balanced Scorecard Reports Develop risk groups research Contribute to annual report Assist with media strategy, liaise Support work programme of NACD
Manage publication process Support capacity building (advice to DTFs Support to NACD work programme  with PR company
 Develop and support NACD & NDST), repeat research grant scheme Explore potential of website
 structures sub comms, RAGs etc Advise on relevant IT support Assist in writing reports
Develop links and interact with other Assist with annual report
bodies both in Ireland and abroad
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Dir RO RA Admin Dir RO RA Admin Dir RO RA Admin Dir RO RA Admin
1 Commissioned Research 220 220 220 220 220 220 220 220 220 220 220 220 220 220 220 220
1.1 Contracted research to be completed 2004
1.2 Contracted research to be completed 2005-2006 53 69 40 48 20 20 20 18 5 8 10 5 0 0 0 0
Population Survey - 3  Bulletins 14 15 5 15
Network Analysis 5 3 5
Risk Group - Travellers 6 10 5
Community Study 5 5 10 5
Family Study 5 5 10 3 5 5 10 3
Homeless Study 2 5 5
ROSIE 8 8 10 5 10 10 5 10 5 8 10 5
National Drug Awareness Campaign 2 5 5 5 5
Capture Recapture 2 source 4 3
HIV Study 2 15 5 5
1.3 Research to be extended or repeated 8 5 10 15 25 30 15 35 25 35 12 30 30 30 10 40
Capture Re-capture 5 3 10 5 10 10 5 15 5 5 2 10 10 10 20
Population Survey 3 2 10 15 20 10 20 20 30 10 20 20 20 10 20
1.4 New Research 10 10 20 40 14 40 40 40 14 30 20 30 10 30 40 30
Risk Group: Sex Workers 2 5 10 5 2 5 5
Risk Group: Early School Leavers 2 5 10 5 2 5 5
Drugs and Crime 5 5 10 20 5 15 10 15 5 10 5 15 5 15 20 15
Rehabilitation 5 5 10 20 5 15 10 15 5 10 5 15 5 15 20 15
2 Grant-aided Research
2.1 Community Research Grant Scheme 2 5 5 5 2 5 30 15 2 5 30 15 5 15 30 20
Four Community Research Projects (evaluation & publication) 2 5 5 5
New project group 2 5 30 15 2 5 30 15 5 15 30 20
2.2 LDTF/RDTF Research Support 2 2 20 2 10 30 20 2 10 30 20 2 10 30 20
3 Internal Research
3.1 Drug Trends Monitoring System 0 30 60 0
Pilot 30 60 20
3.2 Position Papers / Focus Groups (2 per annum) 5 5 30 5 10 20 30 20 10 25 50 20 10 25 50 20
4 Communications
4.1 Communications Strategy 3 1 1 2 3 1 1 2 3 1 1 2 3 1 1 2
4.2 Programme for Key Influencers 15 5 10 15 5 10 20 5 10 20 5 10
4.3 Dissemination Programme 5 40 5 40 10 40 5 40
4.4 Publications / Launches 25 10 10 50 25 10 10 50 25 10 10 50 25 10 10 50
5 Professional Development Work 5 5 5 10 5 5 5 10 5 5 5 10 5 5 5 10
6 Management and Administration 73 53 28 138 73 53 28 138 73 53 39 118 73 53 28 138
6.1 Committee support 24 24 14 60 24 24 14 60 24 24 25 60 24 24 14 60
6.2 Staff meetings 24 24 14 28 24 24 14 28 24 24 14 28 24 24 14 28
6.3 Balanced Scorecard 10 30 10 30 10 30 10 30
6.4 Annual Report 15 5 20 15 5 20 15 5 15 5 20
Total requirements (days) 201 205 209 383 194 204 209 398 184 197 207 350 183 189 204 380
Available days 220 220 220 440 220 220 220 440 220 220 220 440 220 220 220 440
Percentage of Capacity 91% 93% 95% 87% 88% 93% 95% 90% 84% 90% 94% 80% 83% 86% 93% 86%
hRO/TecDir RO RA Admin Dir RA Admin Dir RO RA Admin Dir RO RA AdminDir=Director; RO=Research Officer; RA=Research Assistant
Admin=two admin officers at CO and HEO grades
20082005 2006 2007
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APPENDIX 4:  BUDGET EXPENDITURE FORECAST – ADMINISTRATION 
 
 
Budgeting for 2005-2008 – Administration 
PAY 
  2005 2006 2007 2008 
Salaries incl. PRSI 185,000 200,000 215,000 230,000 
NON-PAY 
Telephone 5,500 6,000 6,500 7,000 
IT/Web 15,000 15,000 15,000 15,000 
Training 10,000 10,000 10,000 10,000 
Travel Expenses (NACD+ 
Staff) 
11,000 12,500 13,750 15,000 
Stationary/Misc, 
 Office Supplies 
2,750 3,000 3,300 3,600 
Office Equipment 6,600 7,200 8,000 8,400 
Publications 50,000 50,000 50,000 50,000 
Petty Cash 1,650 1,800 1,980 2,000 
Office Cleaning 6,050 6,650 7,300 8,000 
Launch/Dissemination 
Events 
20,000 20,000 20,000 20,000 
Postage 5,700 6,200 6,800 7,600 
Rent 800 880 960 1,000 
PR 30,000 30,000 30,000 30,000 
Secretarial Temp Services 15,000 15,000 15,000 15,000 
Sundry  30,000 30,000 30,000 30,000 
Legal 10,000 10,000 10,000 5,000 
        
Totals 405,050 424,230 443,590 457,600 
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APPENDIX 5:  RECOMMENDATIONS OF 2004 NACD REVIEW  
 
The independent review of the work of the NACD put forward a number of recommendations that the 
Committee accepted as being aligned with its own views and these are reflected in the direction and balance of 
this four-year Business Plan. 
 
The main recommendations in relation to the operation of the NACD in its current role are summarised below: 
 
Recommendation 1: The NACD should be continued in its current role  
Recommendation 2: Relationships and co-operation with the NDST should to be developed further 
Recommendation 3: A clarification of the relative roles and functions and the relationship between the 
NACD and the Drug Misuse Research Division of the Health Research Board 
(DMRD) is required.  This should be documented in the form of a service level 
agreement or memorandum of understanding. 
Recommendation 4: The NACD should continue in its present structure and with its current Terms of 
Reference for a further period, that period to coincide with the life of the National 
Drugs Strategy 2001-2008. 
Recommendation 5: The NACD should continue to reduce the number of sub-committee meeting to 
(say) one per quarter, when their focus should primarily be on setting priorities in 
their respective areas. 
Recommendation 6:  The NACD should increase the use of ad-hoc, time limited, groupings such as 
Research Advisory Groups (RAGs) for specific projects. 
Recommendation 7: As far as possible, administrative matters should be dealt with by the Management 
Committee. 
Recommendation 8: An Assistant Research Officer should be appointed to increase the NACD’s 
capacity (This recommendation was not accepted by the Department of Finance) 
Recommendation 9: The NACD should focus on a smaller number of research programmes identified 
as priorities by the sub-committees. 
Recommendation 10: The NACD should develop a strategy for, and focus more of its resources on: 
▪ Development of the national research agenda on drugs 
▪ Analysis and interpretation of its own and other research 
▪ Further development of its role as advisor to Government, through developing 
its capacity to respond rapidly to current issues 
▪ Further development of the necessary networks and processes to make 
optimum use of existing capacity and to develop research awareness and co-
operation amongst key bodies, Departments and Agencies 
▪ Continuation/development of support for capacity building at local and 
community levels. 
Recommendation 11: The NACD should develop a small set of Key Performance Indicators, utilising a 
Balanced Scorecard approach, to support the organisation’s strategic development. 
This will require an appropriate monitoring and reporting system. 
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APPENDIX 6: BALANCED SCORECARD REPORTING FORMS 
 
Overall Performance
Internal efficiency Financial Management Integration
Government Q's Comm'd Research Commitments
Drug Strat. Actions Grant-asst. Research Spending
Internal Research
Project Management
KEY: Components on or ahead of target
Components currently on target but some potential issues
One or more components significantly outside target (i.e. greater than 10%)
Information flows
National Advisory Committee on Drugs
Summary Performance Report for ………………………
Client Service
 
We will establish monthly one page reporting forms for all projects which will inform this 
overview above for the NACD sub committees and main committee. 
Response to Government Requests
Request Date Initiated Original Delivery 
Plan
Current  Forecast Potential Overrun 
(weeks)
Comments / Issues
Actions Required by Drug Strategy
Action Date Initiated Original Delivery 
Plan
Current  Forecast Potential Overrun 
(weeks)
Comments / Issues
On Schedule  
Yes / No
National Advisory Committee on Drugs
Client Service Performance Report for ………………………
On Schedule  
Yes / No
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 Commissioned Research Projects
Research Project Date Initiated Original Delivery 
Plan
Current  Forecast Potential Overrun 
(weeks)
Comments / Issues
Grant-assisted Research Projects
Action Date Initiated Original Delivery 
Plan
Current  Forecast Potential Overrun 
(weeks)
Comments / Issues
Academic Research:
Community Research:
RDTF/LDTF Projects:
Internal Research Projects
Action Date Initiated Original Delivery 
Plan
Current  Forecast Potential Overrun 
(weeks)
Comments / Issues
DTMS Reports
Briefing Papers
Project Management
% Comments / Issues
On Schedule  
Yes / No
National Advisory Committee on Drugs
Internal Performance Report for ………………………
On Schedule  
Yes / No
On Schedule  
Yes / No
Total Number
Projects on Time
Issues raised and resolved
Projects on time or         
Issues Resolved
 
 
Description Comments / Issues
Planned Actual Variance Planned
Current  Forecast Potential 
Variance
Financial Commitments
Spending Against Budget
National Advisory Committee on Drugs
Financial Management Report for ………………………
Year To Date Forecast for Year
 
 
 
 
 
Information flows Target Actual Achieved
%
Inward flow No. of projects submitted to NACD for input or comment
Outward flow No. of NACD publications used by other organisations/Agencies
Comments / Issues
National Advisory Committee on Drugs
Integration Report for ………………………
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APPENDIX 7: NACD SUB COMMITTEE MEMBERSHIP 
Main Committee Sub-Committee Membership
C
on
se
qu
en
ce
s 
EW
ET
Pr
ev
al
en
ce
 
Pr
ev
en
tio
n 
Tr
ea
tm
en
t/R
eh
ab
ilit
at
io
M
an
ag
em
en
t 
Dr Des Corrigan (Chair) x x x x
Dr Mary Ellen McCann (Vice-Chair) x x x
Ms Anna Quigley x x
Dr Eamon Keenan x x
Dr Joe Barry x x
Mr. David Moloney x x x
Ms. Catherine Byrne x x
Ms. Máirín O'Sullivan x
Mr Liam O'Brien x x
Ms Mair
Ms Kathl x
Mr. Brian 
Mr Tony 
Mr. Cathal
Ms Patric
Ms Maria
Dr Hamis
Supt Fi
Mr Willie 
ead Kavanagh x x
een Stack x x x
Melaugh x x
Geoghegan x x
 Morgan x
ia O'Connor x x x
 Corrigan x x
h Sinclair x x x x
nbarr O'Brien x x
Collins x x  
 
 
Co-opted Sub-committee Members 
Co
ns
eq
ue
nc
es
 
EW
ET
Pr
ev
al
en
ce
 
Pr
ev
en
tio
n 
Tr
ea
tm
en
t 
Ms Elaine Butler x
Det Garda Pat Davis x
Dr Ide Delargy x
Mr Gerry Hayes x
Mr John Kelly x x
Ms Pauline Leavy x
Mr Richie Maguire x
Ms Deirdre Mahony x
Mr Tom McGuinn x
Ms Ruby Morrow x
Ms Frances Nangle-Connor x
Dr Daniel O’Driscoll x
Ms Anya Pierce x
Mr Bobby Smith x
Ms Siobhan Stokes MSc x
Ms. Sinead Copeland x
Mr. Evan Breen x  
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Project Title Contractor Output
Cannabis Four researchers from diverse fields of
interest such as pharmacology, public
health, criminology and educational
psychology completed the work. They
are Dr Claire Collins, Mr Johnny
Connolly, Dr Dominique Crowley and Dr
Mark Morgan.
The above report was commissioned by the NACD in response to a
request from the Minister of State to investigate the scientific information
on cannabis. The Report is expected to fill a current gap in knowledge
of cannabis use in Ireland and recommendations will be made to
Government based on the findings. A briefing seminar was held in
Dublin to launch the report. Dissemination has been completed to key
audiences and stakeholders; however additional copies will also be
published in anticipation of a wider interest in the report's findings. The
report is available to download from NACD’s website.
Published in September 2004
Benzodiazepines study Ballymun Youth Action Project This report studies the role of benzodiazepines in the development of
substance misuse problems in Ballymun. The report also explores the
dynamics of supply and demand in a local context, and highlights the
factors that allow the continuance of a relatively high level of
benzodiazepine use within the community.  
Published in October 2004
Drug Prevalence Survey of 10-17 
year olds
Kilbarrack Community Coast Programme This study establishes the patterns and trends of drug misuse in the
Kilbarrack area by young people aged 10 – 17 and examines their
attitudes to drug use, and the risk factors accompanying their use. The
study also assesses the drug use among a sample of early school leavers
and examines the views of community members on the drug situation in
the area. Representing a socially mixed area, the research is important in
providing an indication of drug use and attitudes to drugs of young
people in similar suburban communities around the country.
Published in October 2004
Needs of local Homeless Drug 
Users 
Tallaght Homeless Advice Unit This research examines the links between homelessness and drug use and
the nature of drug use amongst the homeless population in Tallaght. It
also explores the reasons behind their homelessness; examines the
policies and practices of local authorities in relation to the housing of
homeless drug users; and explores the experiences of homeless drug users
with special reference to the policies and practices of homeless services.  
Published in October 2004
Drug Use in Emerging New 
Communities in Ireland
Merchants Quay Ireland This exploratory study examines the patterns of drug use among new
communities; explores the reasons and motivations for drug use;
establishes risks the users may be exposed to; examines the level of
awareness of health promotion / harm minimisation strategies and drug
treatment services; and identifies barriers to accessing services.  
Published in October 2004
APPENDIX 8: OTHER ACHIEVEMENTS JULY TO DECEMBER 2004 
 
APPENDIX 9:  INFORMATION GAPS  
 
The table below sets out the information gaps identified by the Interim Advisory Committee 
in their report to the Minister in February 2000.  We have matched the work undertaken thus 
far by the NACD to these gaps to identify those still remaining.  Most of the remaining gaps 
relate to criminal justice issues and cost effectiveness in delivery of treatment, prevention and 
other interventions. 
   Topic Progress to date 
1. Attendance at drop in centres by clients not 
receiving counselling or medical intervention  
2. Attitudes within society to drug misuse  Population survey 
3. Capacity building in local communities Research Grant Scheme 
4. Cautioning regarding minor drug related offences  
5. Cross border initiatives Population survey 
6. Drug related deaths DMRD are in process of setting up a 
Drugs Related Death Index 
7. Effectiveness of different treatment models ROSIE 
8. Effectiveness of drug policies in different socio-
economic contexts  
9. Experimental/occasional/regular (non medical) 
drug use among 17-25 age groups Population survey 
10. Extent & prevalence of drug misuse in Dublin & 
Nationally 
Capture recapture; network 
analysis; population survey 
11. Families of drug misusers and how all aspects of 
drug misuse affect the family unit 
 
Planned under consequences 
12. Follow up research on links between drugs and 
crime Garda study nearing completion 
13. Formal evaluations of policing operations  
14. Further research on links between poverty and drug 
misuse  
15. Increase in crime, homelessness and drug supply Homeless study underway. 
16. Information flow from hospitals Links with HIPE established 
17. Lack of addiction library facility National Documentation Centre 
18. Link between offences and seizures; indicator of 
level of dealer  
19. Longitudinal evaluations of different prevention 
strategies  
20. Models of resource allocation  
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Topic Progress to date 
21. Number and outcomes of anti-drug operations  
22. Patterns of drug misuse Population survey 
23. Poly drug misuse ROSIE; network analysis; population survey 
24. Population of drug offenders known to the Gardaí Capture recapture 
25. Prescription drug misuse 
Analysis of Benzodiazepine 
Report foreseen 
26. Protective factors Morgan Report and Family Study by Unique Perspectives 
27. Real cost and effectiveness of law enforcement 
prevention and treatment measures 
ROSIE can provide limited data 
on cost of effective treatment 
28. Relapse rate of treated clients ROSIE 
29. Research capturing the experience of users, their 
families and communities throughout the stages of 
their drug misuse 
Community study and family 
study 
30. Sentencing and serving of sentences  
31. Studies on effective counselling ROSIE 
32. Studies regarding intersectoral collaboration and 
the difficulties in achieving it in practice In house review underway 
33. The cost to society of the drug problem  
34. The effect of heroin on local communities Community study 
35. The experience of drug misuse by drug misusers 
and former drug misusers 
Qualitative interviews in network 
analysis 
36. The experience of people no longer in contact with 
the services  
37. The physical effects of drug misuse and the kind of 
information that is required to inform the general 
health strategy around drug misuse rather than 
simply a treatment focused approach 
National Drug Awareness 
Campaign 
38. The impact of drug misuse on the ability to 
maintain social relationships  
39. Travellers’ experience of the drug problem Commissioned in 2003 
40. Treatment and rehabilitation outcomes in Ireland ROSIE 
41. Trends among young people Population survey & analysis of data in ESPAD 2003 
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